The companies will work together to reduce cost and improve the outcomes of total joint replacement procedures. Conformis develops and sells customized implants for joint replacement surgery.
“Conformis has transformed joint replacement technology, which has led to better patient outcomes,” said Regent Surgical Health CEO Chris Bishop. “Our collaboration builds on that and allows us to improve clinical pathways for patients while enhancing the value proposition for surgeons, employers and payers.”
Regent operates 26 ASCs, 21 hospital joint ventures, 14 total joint replacement centers and three bundled-payment entities.
“It is clear that payers and providers want to establish a business and clinical care model that results in better patient outcomes and enables delivery of total joint arthroplasty resulting in overall lower cost of care,” said Conformis CEO Mark Augusti.
More articles on orthopedics and TJR:
ASC total joint program bundles, vendors & more — 3 insights from an administrator
3 ASCs adding surgical robots
More efficient anterior hip replacements: the role of orthopedic tables
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.